26198568|t|Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of alpha7 Nicotinic Acetylcholine Receptor.
26198568|a|Simvastatin (SV) has been reported to improve cognitive deficits in Alzheimer's disease. Here, we show that chronic administration of SV (20 mg/kg) for 30 days in adult mice (SV mice) enhanced spatial cognitive performance as assessed by Morris water maze and Y-maze. To explore mechanisms underlying SV-enhanced spatial cognition, we further examined synaptic properties and long-term potentiation (LTP) in hippocampal CA1, hippocampal alpha7nAChR expression, and Akt and ERK2 phosphorylation. In comparison with controls, the SV administration caused increase in presynaptic glutamate release and amplitude of NMDAr-dependent LTP (LTP-augmentation), and decrease in threshold of NMDAr-independent LTP induction (LTP-facilitation). The supplement of isoprenoid farnesyl pyrophosphate (FPP) by applying farnesol (FOH) could abolish the spatial cognitive potentiation, increased glutamate release, and LTP-augmentation/facilitation in SV mice. Expression of alpha7nAChR, but not alpha4beta2nAChR, was increased in hippocampal pyramidal cells of SV mice with the reduction of transcription factor AP-2alpha, which were abolished by FOH. Levels of Akt and ERK2 phosphorylation in SV mice were elevated, which were suppressed by FOH or alpha7nAChR antagonist methyl-lycaconitine (MLA). In hippocampal slices obtained from SV mice, acute perfusion of MLA blocked the increased glutamate release, whereas FOH, PI3K inhibitor LY294002, or MEK inhibitor U0126 could not. In the slices of SV mice, the perfusion of MLA or U0126, but not FOH, abolished the LTP-augmentation and LTP-facilitation. By contrast, LY294002 prevented the LTP-facilitation but failed to affect the LTP-augmentation. The findings indicate that the administration of SV through reducing FPP increases alpha7nAChR expression and alpha7nAChR-related Akt and ERK2 phosphorylation, leading to LTP enhancement and spatial cognitive potentiation.
26198568	0	11	Simvastatin	Chemical	MESH:D019821
26198568	143	154	Simvastatin	Chemical	MESH:D019821
26198568	156	158	SV	Chemical	MESH:D019821
26198568	189	207	cognitive deficits	Disease	MESH:D003072
26198568	211	230	Alzheimer's disease	Disease	MESH:D000544
26198568	277	279	SV	Chemical	MESH:D019821
26198568	312	316	mice	Species	10090
26198568	318	320	SV	Chemical	MESH:D019821
26198568	321	325	mice	Species	10090
26198568	444	446	SV	Chemical	MESH:D019821
26198568	580	591	alpha7nAChR	Gene	11441
26198568	608	611	Akt	Gene	11651
26198568	616	620	ERK2	Gene	26413
26198568	671	673	SV	Chemical	MESH:D019821
26198568	720	729	glutamate	Chemical	MESH:D018698
26198568	755	760	NMDAr	Gene	14810
26198568	824	829	NMDAr	Gene	14810
26198568	894	904	isoprenoid	Chemical	MESH:D013729
26198568	905	927	farnesyl pyrophosphate	Chemical	MESH:C004808
26198568	929	932	FPP	Chemical	MESH:C004808
26198568	946	954	farnesol	Chemical	MESH:D005204
26198568	956	959	FOH	Chemical	-
26198568	1021	1030	glutamate	Chemical	MESH:D018698
26198568	1077	1079	SV	Chemical	MESH:D019821
26198568	1080	1084	mice	Species	10090
26198568	1100	1111	alpha7nAChR	Gene	11441
26198568	1187	1189	SV	Chemical	MESH:D019821
26198568	1190	1194	mice	Species	10090
26198568	1238	1247	AP-2alpha	Gene	21418
26198568	1273	1276	FOH	Chemical	-
26198568	1288	1291	Akt	Gene	11651
26198568	1296	1300	ERK2	Gene	26413
26198568	1320	1322	SV	Chemical	MESH:D019821
26198568	1323	1327	mice	Species	10090
26198568	1368	1371	FOH	Chemical	-
26198568	1375	1386	alpha7nAChR	Gene	11441
26198568	1398	1417	methyl-lycaconitine	Chemical	MESH:C054634
26198568	1419	1422	MLA	Chemical	MESH:C054634
26198568	1461	1463	SV	Chemical	MESH:D019821
26198568	1464	1468	mice	Species	10090
26198568	1489	1492	MLA	Chemical	MESH:C054634
26198568	1515	1524	glutamate	Chemical	MESH:D018698
26198568	1542	1545	FOH	Chemical	-
26198568	1562	1570	LY294002	Chemical	MESH:C085911
26198568	1575	1578	MEK	Gene	17242
26198568	1589	1594	U0126	Chemical	MESH:C113580
26198568	1623	1625	SV	Chemical	MESH:D019821
26198568	1626	1630	mice	Species	10090
26198568	1649	1652	MLA	Chemical	MESH:C054634
26198568	1656	1661	U0126	Chemical	MESH:C113580
26198568	1671	1674	FOH	Chemical	-
26198568	1742	1750	LY294002	Chemical	MESH:C085911
26198568	1874	1876	SV	Chemical	MESH:D019821
26198568	1894	1897	FPP	Chemical	MESH:C004808
26198568	1908	1919	alpha7nAChR	Gene	11441
26198568	1935	1946	alpha7nAChR	Gene	11441
26198568	1955	1958	Akt	Gene	11651
26198568	1963	1967	ERK2	Gene	26413
26198568	Positive_Correlation	MESH:D019821	26413
26198568	Positive_Correlation	MESH:D019821	11441
26198568	Cotreatment	MESH:C004808	MESH:D005204
26198568	Positive_Correlation	MESH:D019821	11651
26198568	Association	11441	26413
26198568	Negative_Correlation	MESH:C054634	11651
26198568	Negative_Correlation	MESH:C054634	26413
26198568	Association	MESH:D019821	21418
26198568	Negative_Correlation	MESH:C054634	11441
26198568	Positive_Correlation	MESH:C004808	11441
26198568	Positive_Correlation	MESH:C004808	26413
26198568	Positive_Correlation	MESH:D019821	MESH:D003072
26198568	Positive_Correlation	MESH:C004808	11651
26198568	Association	11441	11651
26198568	Negative_Correlation	MESH:C054634	MESH:D019821
26198568	Positive_Correlation	MESH:C004808	MESH:D018698
26198568	Negative_Correlation	MESH:C054634	MESH:D018698
26198568	Negative_Correlation	MESH:D005204	MESH:D019821
26198568	Positive_Correlation	MESH:D019821	14810
26198568	Negative_Correlation	MESH:C113580	17242
26198568	Negative_Correlation	MESH:D019821	MESH:D000544
26198568	Positive_Correlation	MESH:D005204	MESH:D018698
26198568	Positive_Correlation	MESH:D018698	MESH:D019821

